Catena Biosciences vs Decoda Health

Side-by-side comparison of AI visibility scores, market position, and capabilities

Catena Biosciences leads in AI visibility (32 vs 19)

Catena Biosciences

EmergingHealthcare

General

US YC W21 protein conjugation technology for homogeneous ADCs and biologics at $9.1M total ($2.35M seed May 2024 LongeVC/Caffeinated) and $750K revenue Jun 2025; MPC platform competing with Ajinomoto and Abzena for precise ADC conjugation services.

AI VisibilityBeta
Overall Score
D32
Category Rank
#418 of 1167
AI Consensus
50%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
25
Gemini
39

About

Catena Biosciences is a United States-based biotechnology company — backed by Y Combinator (W21) with $9.1 million in total funding including a $2.35 million seed round in May 2024 from LongeVC, CA Innovation Fund, Civilization Ventures, Pioneer Fund, Freeflow Ventures, Caffeinated Capital, and BrightEdge Capital, plus NIH SBIR grants — developing next-generation protein conjugation technology that enables the rapid, selective attachment of functional payloads (drugs, labels, polymers, other proteins) to therapeutic proteins using natural amino acids as conjugation handles, generating $750,000 in annual revenue as of June 2025 and serving pharmaceutical companies and researchers developing antibody-drug conjugates (ADCs), bispecific antibodies, vaccine adjuvants, and next-generation protein therapeutics for autoimmune disorders, oncology, and infectious disease.

Full profile

Decoda Health

EmergingHealthcare

General

SF AI healthcare administration automating medical coding, billing, and claims for clinics with 30% cost savings and 20% fewer denials; YC S23 $4.5M competing with Waystar for revenue cycle management automation.

AI VisibilityBeta
Overall Score
D19
Category Rank
#998 of 1167
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
13
Perplexity
23
Gemini
18

About

Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Graphene Ventures, and Orange Collective — providing medical clinics and healthcare providers with autonomous AI agents that handle medical coding, billing, claims submission, denial management, scheduling coordination, and patient payment collection, automating 80%+ of the repetitive administrative tasks that currently consume 30-40% of healthcare provider revenue in overhead costs. Founded in 2023 by Daniyal Afzal, James Oswald, and Kevin Cheng, Decoda's AI agents deliver 30% reduction in coding costs, 20% reduction in claim denials, and claims processing in seconds versus the days that manual coding and submission require.

Full profile

AI Visibility Head-to-Head

32
Overall Score
19
#418
Category Rank
#998
50
AI Consensus
71
stable
Trend
stable
39
ChatGPT
13
25
Perplexity
23
39
Gemini
18
42
Claude
19
25
Grok
11

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.